ISPOR 2022 Highlights
ECONCARE team presented in person five research posters during ISPOR Europe 2022 on topics related to health economics and outcomes research (HEOR).
The ECONCARE team attended this year's conference and presented interesting findings in five posters that you can find below:
Cost-Effectiveness of Brexucabtagene Autoleucel (Brexu-cel, CAR-T) for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma in Greece (Top 5% Finalist for the ISPOR Europe 2022 Research Presentation Awards ?)
A Budget Impact Analysis of Introducing a New Combination of Atorvastatin and Ezetimibe in Greece
ECONCARE team presented in person five research posters during ISPOR Europe 2022 on topics related to health economics and outcomes research (HEOR).
The ECONCARE team attended this year's conference and presented interesting findings in five posters that you can find below:
Cost-Effectiveness of Brexucabtagene Autoleucel (Brexu-cel, CAR-T) for the Treatment of Relapsed/Refractory Mantle Cell Lymphoma in Greece (Top 5% Finalist for the ISPOR Europe 2022 Research Presentation Awards ?)
A Budget Impact Analysis of Introducing a New Combination of Atorvastatin and Ezetimibe in Greece